Nuvation Bio Statistics
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.86-0.02 (-0.41%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Nuvation Bio by the numbers
Nuvation Bio has a market capitalization of $1.71 billion based on 350.12M shares outstanding. With trailing EPS of $-0.44, Nuvation Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.2% below its 50-day average and 15.0% below its 200-day average.
Average daily trading volume is 5.65M shares, or about $27.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NUVB valuation vs. peer median
| Metric | NUVB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.71B | $1.68B | +2% |
| Avg. volume | 5.65M | 1.17M | +382% |
Peer median across 8 companies: GENB, SEPN, BRVE, ANIP, BHVN, XNCR, CMPS, QURE.
Valuation
- Market cap
- $1.71B
- EPS (TTM)
- $-0.44
- Shares outstanding
- 350.12M
Price and trading
- Previous close
- 4.88
- Open
- 4.81
- Day range
- 4.79 – 4.95
- 52-week range
- 3.36 – 9.75
- 52-week change
- +32.79%
- Beta
- —
- Volume
- 5.45M
- Average volume
- 5.65M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 1.71B
- Forward Pe
- -324.00
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.75
- Week52 Low
- 3.36
- Avg Volume
- 5.65M
- Shares Outstanding
- 350.12M
- Ma50
- 6.24
- Ma200
- 5.72
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -50.15%
- Pct From52w Low
- 44.64%